Research Article

Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients

Table 4

Correlation between LVM and LVM/BSA and some demographic and laboratory parameters among the studied subgroups.

LVMLVMI
rr

S. sclerostin (ng/ml)−0.3290.010−0.2570.046
S. Dkk-1 (pg/dl)−0.4270.001−0.3240.012
Age (years)0.4090.0010.3520.007
BMI0.2190.085−0.1990.118
BSA0.2780.027−0.3050.015
HD_duration−0.1530.2640.0150.979
Gender−0.1120.3800.1530.232
HTN0.3000.0190.2470.054
HB (gm/dl)−0.2450.057−0.2990.019
S. albumin (gm/dl)−0.2290.076−0.2940.021
Syst_BP (mmhg)0.2430.0590.2490.053
Diast BP (mmhg)0.2510.0510.2110.103
S. cholesterol−0.1260.334−0.2050.112
S. TG (mg/dl)−0.0240.855−0.1790.166
S. HDL (mg/dl)−0.2680.036−0.1610.214
S. LDL (mg/dl)−0.0760.563−0.1580.225
AVC0.4170.0010.464< 0.001
MVC0.2970.020.3600.004
Mid_arm_circ (cm)0.0670.609−0.4230.001
Waist_circ (cm)0.2040.115−0.1280.326
Dry_weight (kg)0.2820.028−0.2860.026
Kt/V−0.0460.7230.1830.158
S. Ca (mg/dl)−0.0850.514−0.0740.573
S. PO4 (mg/dl)0.2420.060−0.0280.831
iPTH (pg/dl)0.0230.787−0.0350.861

Spearman’s correlation used. Significant at ; highly significant at . LVM: left ventricular mass; LVM/BSA: left ventricular mass/body surface area; S. Dkk-1: serum Dickkopf-1; BMI: body mass index; BSA: body surface area; HD: hemodialysis; HTN: hypertension; HB (gm/dl): hemoglobin concentration (gram/deciliter); Syst_BP: systolic blood pressure; Diast BP: diastolic blood pressure; mmhg: millimeter Mercury; S. TG; serum triglyceride; S. HDL: serum high-density lipoprotein; S. LDL: serum low-density lipoprotein; AVC: aortic valve calcification; MVC: mitral valve calcification; circ: circumference; Kt/V: kinetic time/volume; S. Ca: serum calcium; S. PO4: serum phosphorus; iPTH: intact parathyroid hormone; mg/dl: milligram/deciliter; pg/dl: picogram/deciliter; ng/dl: nanogram/deciliter.